Bio Plus Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Operating Revenue	96,802	66,410	65,043	56,719	37,418	24,367
Other Revenue	-0	-0	-	-	-	-
Revenue	96,802	66,410	65,043	56,719	37,418	24,367
Revenue Growth (YoY)	81.01%	2.10%	14.68%	51.58%	53.56%	43.16%
Cost of Revenue	29,947	23,875	25,525	22,942	13,790	7,818
Gross Profit	66,855	42,535	39,518	33,776	23,628	16,549
Selling, General & Admin	30,161	14,172	8,170	6,534	4,339	2,719
Research & Development	2,861	1,477	1,165	1,081	435.18	276.05
Amortization of Goodwill & Intangibles	430.87	436.81	340.2	203.14	111.76	81.73
Other Operating Expenses	628.79	203.06	155.02	59.11	11.46	8.28
Operating Expenses	38,994	18,867	11,493	8,176	5,402	4,222
Operating Income	27,862	23,667	28,026	25,600	18,226	12,327
Interest Expense	-309.75	-263.43	-60.28	-13.3	-521.47	-58.16
Interest & Investment Income	884.62	1,796	2,439	1,074	158.26	18.18
Earnings From Equity Investments	-215.7	-	-	-311.08	-327.99	-
Currency Exchange Gain (Loss)	705.32	1,625	200.64	461.34	304.74	-184.63
Other Non Operating Income (Expenses)	-7,566	-8,037	2,103	129.56	-2,107	34.9
EBT Excluding Unusual Items	21,360	18,788	32,708	26,941	15,733	12,138
Gain (Loss) on Sale of Investments	244.57	87.62	41.03	639.04	-	-
Gain (Loss) on Sale of Assets	109.12	592.74	-8.52	-81.04	-	-3.4
Asset Writedown	-	-	-	-28.02	-1,565	-
Other Unusual Items	-1,804	-1,804	-	-	-	-
Pretax Income	19,910	17,664	32,740	27,471	14,168	12,134
Income Tax Expense	-952.56	153.09	5,318	6,763	3,495	2,431
Earnings From Continuing Operations	20,862	17,510	27,422	20,708	10,673	9,703
Minority Interest in Earnings	-4,812	-3,359	-1,841	428.96	51.68	-
Net Income	16,050	14,151	25,581	21,137	10,725	9,703
Net Income to Common	16,050	14,151	25,581	21,137	10,725	9,703
Net Income Growth	-9.83%	-44.68%	21.02%	97.09%	10.53%	72.55%
Shares Outstanding (Basic)	58	57	58	57	52	50
Shares Outstanding (Diluted)	64	60	61	57	52	50
Shares Change (YoY)	3.75%	-0.28%	5.64%	10.68%	3.82%	-2.75%
EPS (Basic)	276.52	249.20	444.85	371.84	207.02	194.39
EPS (Diluted)	237.82	246.92	433.36	371.18	206.94	188.75
EPS Growth	-22.02%	-43.02%	16.75%	79.36%	9.64%	65.95%
Free Cash Flow	-44,940	-68,513	-803.37	6,829	-1,959	8,958
Free Cash Flow Per Share	-697.44	-1133.97	-13.26	119.07	-37.80	179.45
Dividend Per Share	50.000	50.000	70.000	70.000	-	-
Dividend Growth	-28.57%	-28.57%	-	-	-	-
Gross Margin	69.06%	64.05%	60.76%	59.55%	63.15%	67.92%
Operating Margin	28.78%	35.64%	43.09%	45.14%	48.71%	50.59%
Profit Margin	16.58%	21.31%	39.33%	37.27%	28.66%	39.82%
Free Cash Flow Margin	-46.42%	-103.17%	-1.23%	12.04%	-5.24%	36.76%
EBITDA	32,008	26,937	30,516	27,487	19,524	13,338
EBITDA Margin	33.06%	40.56%	46.92%	48.46%	52.18%	54.74%
D&A For EBITDA	4,147	3,270	2,490	1,887	1,298	1,010
EBIT	27,862	23,667	28,026	25,600	18,226	12,327
EBIT Margin	28.78%	35.64%	43.09%	45.14%	48.71%	50.59%
Effective Tax Rate	-	0.87%	16.24%	24.62%	24.67%	20.04%
Advertising Expenses	-	1,045	230.71	228.49	32.22	13.29

Source: S&P Global Market Intelligence. Standard template. Financial Sources.